During this time, he published the first European report on the advantages of injection snoreplasty to treat sleep respiratory disorders; and in 2006 he was the first doctor to place a soft palate in Spain. He is also the author of the first app in the world used for the treatment of sleep apnoea through telemedicine.

Dr O'Connor is the President of the Spanish Commission of the Spanish Society of Respiratory Disorders. He is also a member of the European Sleep Research, the American Otorhinolaryngology Academy, the Spanish Otorhinolaryngology Society, Ibero-American Otorhinolaryngology Society and Andalusian Otorhinolaryngology Society.

Professional Experience

• Lecturer in Otorhinolaryngology at the Faculty of Medicine of the University of Seville.

• Co-Director of the Otorhinolaryngology Unit of the Quironsalud Marbella Hospital and Quironsalud Campo de Gibraltar Hospital since 2006.

• First European report on the use of injection snoreplasty to treat sleep respiratory disorders in 2005.

• First soft palate implant in Spain and first publication in the country on this area of medicine (2006).

• Author of the first manuscript on the use of radiofrequency to treat hypertrophy of nasal turbinates in paediatric patients in sleep respiratory disorders.

• Author of the first lateral pharyngoplasty in Europe 2010.

• Author of the first expansion pharyngoplasty in Spain in 2010.

• First doctor in Spain to introduce myofunctional therapy in a sleep unit in order to treat obstructive sleep apnoea.

• Author of the first app in the world used to treat sleep apnoea through telemedicine.

• International revisor of papers about sleep respiratory disorders in Laryngoscope, Journal of Oral Rehabilitation, Plos One, Nature and Science of Sleep, International Journal of Paediatric Otorhinolaryngology, Spanish Acta ORL, Stockholm Acta ORL.

Otorhinolaryngology (ENT) and head and neck surgery are a medico-surgical speciality dealing with the study, diagnosis and treatment of the pathologies affecting the ear (hearing and balance), the upper airways (nose, paranasal sinuses, pharynx and larynx), sense of smell, oral cavity, neck and salivary glands.

The ENT Unit of Quirónsalud Marbella Hospital comprises a team of outstanding specialists in this medical field, who are a reference at national and international level, on account of their research work, implementation and development of avant-garde techniques, as well as regular publications in highly-influential scientific journals.

He graduated in Medicine at the Malaga University and specialised in Urology at the Carlos Haya Hospital in the same province.

He travelled to the United States in 2012 for a study stay at the Memorial Sloan-Kettering Cancer Centre in New York. Specifically, at the Oncology Unit leaded by Dr Karim Touijer.

Years later, he consolidated his training with specialist courses in lower urinary tract surgery, advanced renal surgery, urinary incontinence and pelvic floor surgery, male urology surgery at the Cardenal Herrera University in Valencia and a Master in the Update of Urologic Surgery at the Cardenal Herrera University.

Professional Experience

• Urology Consultant at the Poniente Hospital 2016.

• Urology Consultant in Área Sanitaria Norte 2016-2017

• Urology Consultant. Carlos Haya Hospital, Malaga 2017-2020.

• Member of the Renal Transplant Unit of the Carlos Haya Hospital, Malaga 2017-2020.

• Co-founder of the Urologic Surgery Institute of Malaga 2019

• Head of the Urology Unit at the Quirónsalud Marbella Hospital 2019- currently

Scientific/ research activities

• Clinical Mentor of medical students of the Faculty of Medicine of Malaga. 2016-2020

• Author of multiple articles for national and international journals, contributions and editor of the “Manual of Basic Urologic Pathologies in Primary Care and A&E”.

The Quirónsalud Marbella Hospital Urology Unit deals with the study, diagnosis and treatment of the conditions affecting the urinary system, the suprarenal glands and the retroperitoneum of both male and female patients, as well as the male reproductive system.

The team of experts and the nursing team in this Unit have vast expertise in the diagnosis and treatment of the various pathologies treated by this speciality.

We cover all the medical, preventative and surgical aspects in order to offer early detection, an adequate diagnosis and an accurate treatment. Our main objective is to offer the highest quality in humane treatment and scientific knowledge with a clear and decisive vocation of patient service.

The Urology Unit performs its activities at the A&E Unit (helping with any urologic emergency 24 hours a day and 365 days a year) and at the Outpatient Consultations Unit (helping patients with an appointment from Monday to Friday, morning and afternoon)

Dr Rivera obtained his Degree in Medicine and Surgery at the University of Seville and continued his academic training until he completed a University Master in Tissue Engineering at the Histology Department of the University of Granada and later obtained the speciality in Plastic, Repair and Cosmetic Surgery at the Virgen de las Nieves (Granada) University Hospital.

Dr Rivera has developed extensive experience in the area of surgery, where he has been in practice for over ten years. Always at the forefront of new technologies applied to surgical techniques, he is a habitual participant in specialist scientific forums as well as national and international conventions.

Professional Experience

• 2007-2012 - Plastic, Repair and Cosmetic Surgery Resident Doctor at the Virgen de las Nieves (Granada) University Hospital

• May 2012 - Currently, Co-director of the Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Marbella Hospital.

• May 2013 - Currently, Co-director of the Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Campo de Gibraltar Hospital.

• He has also been part of General Surgery and Traumatology, Maxillofacial Surgery and Major Burn Ward teams. Additionally, he has cooperated with the Plastic Surgery Unit of the Teknon Clinic in Barcelona.

The Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Marbella Hospital performs the most advanced treatments in Cosmetic Surgery and Medicine with the total guarantee that the patient is treated within a hospital environment, thus ensuring the highest level of safety during the surgical procedure and the recovery time.

Our team of specialists combine their solid professional expertise in the correction of congenital or acquired anomalies affecting the shape or the appearance of your body. As this speciality deals with various areas and systems, the experts often work in conjunction with other medical areas.

With regards to female cosmetic surgery, the Plastic, Cosmetic and Repair Surgery Unit of the Quirónsalud Marbella Hospital specialises in the augmentation and reduction of breasts, breast lift, tuberous breast correction, abdominoplasty, arms and thigh lift, surgery of the genitalia and reconstructive surgery after a mastectomy at the Breast Cancer Unit. We also perform male breast reduction and facial surgical procedures such as facial lift, eyelid surgery, nose remodelling, ear correction surgery and double-chin surgery.

Dr Romero Imbroda is an academic of the Royal Academy of Medicine of Eastern Andalusia and a Fellow of the European Board of Neurology, as well as a Member of the Board of Directors of the

Andalusian Society of Neurology. He combines his medical practice with his teaching role at the University of Granada, where he is a Lecturer and has been a Member of the Internal Residential Doctor Assessment Committee in Melilla until 2017.

He is the author of several national and international scientific publications. He has also participated in research projects associated with treatments for multiple sclerosis.

Professional Experience:

• 2020: President of the Andalusian Society of Neurology

• 2019: Head of the Units at the Quirónsalud Malaga and Marbella Hospitals

• 2017-2021: Neurologist at the Regional Malaga University Hospital.

• 2016-2017: Lecturer at the University of Granada.

• 2009-2017: Neurologist at the Imbrain Neuroscience Clinic. Melilla.

• 2009-2017: Neurologist at the Melilla Hospital.

• 2008-2009: Neurologist at the Virgen de las Nieves Hospital. Granada.

• 2004-2008: Neurologist at the Carlos Haya Hospital. Malaga.

Academic Training:

• 2017: Innovation and Leadership in Neurology. Business Institute. Madrid.

• 2014: Educational Commission for Foreign Medical Graduates. United States.

• 2011-2012: Management of Integrated Health Services. ESADE. Madrid.

• 2010: Neurologists for the Future. Spanish Neurology Society.

• 2010: Master in Tissue Engineering. University of Granada.

• 2010: Doctorate at the University of Granada. Summa Cum Laude. 2010.

• 2004-2008: Neurology specialist at the Carlos Haya Hospital. Malaga.

• 1997-2003: University Graduate in Medicine at the University of Granada.

The Neurology Unit of the Quirónsalud Marbella Hospital specialises in the study and treatment of conditions associated to the nervous system, the brain, the spinal cord, the peripheral nerves and the muscles. We have the most advanced technology that enables us to make accurate and personalised diagnoses and treatments in the study of patients with complex diagnoses and treatments (MRI, CT scan,electroencephalogram, transacranial doppler ultrasound, cerebral arteriogramand neuropschycological testing).

We offer our patients highly-specialised treatments for cerebrovascular and neuromuscular diseases, Parkinson's Disease, headaches and migraine, epilepsy, multiple sclerosis, peripheral neuropathies, infections of the nervous system, movement disorders, dementia and other cognitive conditions, paediatric neurology, sleep disorders, tumours and complications deriving from injuries to the spine and the head.

Dr. Jose Hinojosa Mena-Bernal is the Head of Neurosurgery at SJD Barcelona Children’s Hospital. He specializes in pediatric neuro-oncology, neuroendoscopy, and minimally invasive surgery. He holds the presidency of the Spanish Society of Pediatric Neurosurgery. Dr. Hinojosa trained at Montefiore Medical Center in the USA and the University of Heidelberg.

• Author of over 90 scientific publications in international medical journals.
• Performs complex procedures including DBS, CyberKnife, and Spina Bifida surgery.
• Former Head of Neurosurgery at major Spanish centers like Hospital Niño Jesús.
• Active member of the ISPN and European Association of Neurosurgical Societies.

グラウス博士の研究分野は、腫瘍随伴症候群です。彼はこれらの診断基準を初めて厳密に定義した専門家パネルを率いました。

彼の研究は、基礎腫瘍が脳神経系への自己免疫攻撃を引き起こすという免疫仮説を確認するうえで重要でした。彼が特定した抗体は現在、これらの症候群の診断に広く使用されています。

彼の臨床的専門知識には、神経膠腫と一次性脳リンパ腫の診断と管理、癌治療に由来する神経毒性が含まれます。最近では、免疫チェックポイント阻害剤による治療や造血幹細胞移植に関連する神経学的合併症に関心を持っています。
 

教育

1976年にバルセロナ自治大学で医学の学位を取得。

• 1982年にバルセロナ自治大学で博士号を取得。
   
• バルセロナでの神経内科のレジデンシーと、ニューヨーク、米国のメモリアル・スローン・ケタリングがんセンターでの神経腫瘍学フェローシップ。

履歴

• 現在、IDIBAPSの名誉研究員。
• 欧州神経腫瘍学会（EANO）の創設者および元会長
   
• リヨン大学のホノリス・カウサ博士の称号。
• 2018年までバルセロナの病院クリニックの神経科の主任
   
• 病院クリニックに関連するアウグスティン・ピ・スニエール生物医学研究所（IDIBAPS）の神経免疫プログラムのコーディネーター。

.

フェルナンド・アズピロズ・ビダウール医師は、35年以上の経験を持つ消化器科専門医であり、消化管研究、腸疾患、腸の運動性、内臓の感受性、腸ガスの動態などのサービスを提供しています。

• 1977年にスペインのバリャドリッド大学で医学の学位を取得
• マドリードのサンカルロス大学病院で一般外科のレジデンスプログラムを修了
• メイヨークリニックの消化管研究ユニットで3年間のフェローシップを完了
• 臨床実践は機能的な消化管問題に焦点を当てています
• 1999年に消化器病研究でジャンセン賞を受賞
• 欧州神経消化器病学協会の会長
• 国際運動性グループの評議員

アントニオ・デ・ラシー・フォルトゥニー博士は、25年の経験を持つがん外科医です。医師は、直腸と結腸のがん治療、減量手術、食道がんの治療を専門としています。

この外科医は15,000を超える外科手術を行ってきました。デ・ラシー博士は、毎年1,000件以上の介入を、低侵襲技術（腹腔鏡手術およびロボット手術）を使用して実施しています。

アントニオ・デ・ラシー博士は、国際医療コミュニティ、学会、協会のメンバーです。彼はヨーロッパの外科医-内視鏡医協会の会長を務めています。この医師は、先進技術と腹腔鏡手術の研究に関する国際コースの講師です。

デ・ラシー・フォルトゥニー博士は、消化器外科手術の世界的に有名なパイオニアの一人とされています。彼は以下のような外科技術を初めて実施した外科医です：

• デ・ラシー博士は、口を通して胆嚢を取り除く世界で初めての専門家になりました。入院後3日目に患者が退院しました。
• 2010年に、この医師は大腸をを取り除く世界で最初の医師となりました。
• この医師は、結腸および直腸がんのための腹腔鏡手術の創始者です。2009年に新しい技術TaTME（経肛門的全直腸間膜切除術）を用いて、世界で初めて直腸の摘出手術を行いました。今、彼は外科医に知識を提供し、教えています。
• デ・ラシー・フォルトゥニー博士は、自然の開口部を通じて腹腔へのアクセスを提供する経管的内視鏡外科手術（NOTES）方法のパイオニアです。

リンパ腫と慢性リンパ性白血病の専門家として、彼と彼のチームは、血液疾患の分析とこの種の病気の新しい治療のための新技術の革新を達成しました。

ボッシュ教授は、慢性リンパ性白血病(CLL)の分野で世界的に最も評価の高い指導者の一人であり、CLLおよび他のリンパ増殖性疾患に関する臨床および基礎研究を行い、特にCLLの分子病態発生と新しい治療アプローチの開発に焦点を当てています。

ボッシュ教授は現在、フェーズ1からフェーズ3までの80以上の研究を進めており、それによりボッシュ教授の研究により、今後数年間で新しい薬剤と適応症が利用可能になることを意味しています。

教育

• 1988年にバルセロナ大学医学部を卒業。
• 1997年にバルセロナ大学で、慢性リンパ増殖性疾患におけるシグリンD1の過剰発現を研究し、イライアス・カンポ教授の指導の下で博士号を取得。
• ニューヨークのコロンビア大学がん遺伝学研究所でリッカルド・ダラ＝ファヴェラ教授の研究室で2年間の博士後研究。
• 2000年にバルセロナ・クリニック病院で慢性リンパ性白血病(LLC)の研究者。

キャリア

• 慢性リンパ性白血病の研究のためのスペイングループ（GELLC）の会長で、臨床試験分野を率いています。
• 1995年以降、CLLに関する臨床試験の開発に関与し、CLLの予後と治療の評価に多くの貢献をしています。
• 2004年からIOBオンコロジー研究所の血液学部長。
• 2009年からバルセロナのバル・デブロン大学病院の血液学部長および実験血液学研究室のディレクター。

出版物

• 「The New England Journal of Medicine」、「Nature Medicine」、「Cancer Cell」、「Blood」、「Journal of Clinical Oncology」、「Leukemia」など、権威ある科学誌に100以上の記事を発表しました。
• CLLおよび他のリンパ増殖性疾患に関するいくつかのレビューおよび書籍の章の共著者。

教育活動

バルセロナのバル・デブロン大学病院の血液学教授。

彼女の主な研究の関心は、血管新生、DNA修復メカニズム、免疫学にあり、卵巣癌、子宮頸癌、子宮内膜癌の臨床試験のいくつかのシリーズで主任研究者を務めています。

彼女は婦人科腫瘍に関する多数のプロジェクトを主導し、関与しています。彼女は様々な会議で100以上の出版物とプレゼンテーションの著者です。

育成

• 1994年にマドリードコンプルテンセ大学で医学および外科学の学位を取得。
   
• マドリードコンプルテンセ大学にある「プリンセサ大学病院」で医学腫瘍学 (MD) に特化。
   
• バルセロナ自治大学で博士号を取得。

実績

• GEICOグループ（スペイン卵巣癌研究グループ）の共同議長としての執行委員会メンバー。
   
• ヨーロッパ医学腫瘍学会（ESMO）での婦人科トラックの教員であり、GOGのスペイン代表。
   
• GEICO代表としてGCIGグループの子宮頸部委員会およびフェーズII委員会のスペイン代表。
   
• アメリカ臨床腫瘍学会（ASCO）、ヨーロッパ医学腫瘍学会（ESMO）、スペイン医学腫瘍学会（SEOM）の積極的なメンバー。

この医師は乳がんと内分泌治療を専門としており、補助療法および転移性疾患におけるホルモン療法への抵抗を克服することに焦点を当てています。乳がんおよびメラノーマに関する第1相、第2相、第3相の研究に積極的に参加しており、パルボシクリブやリボシクリブのようなcdk4/6阻害剤を含む新薬の承認に貢献しています。これらは転移性乳がんのためのものであり、ペムブロリズマブ、ニボルマブ、イピリムマブのような免疫療法治療はメラノーマのためのものです。この医師は、バル・デ・エブロン大学病院およびバル・デ・エブロン腫瘍学研究所の乳がんユニットおよびメラノーマユニットのメンバーです。<\/p>

プラット博士は、乳がんの臨床検査結果の臨床応用に長年の研究関心を持つ臨床科学者であり、特に遺伝子発現や乳がんの異なる内因性分子サブタイプの臨床的影響に関心を持っています。また、彼はスペインの乳がん協同組合グループSOLTIで新薬や新しいアプローチの臨床試験を設計し、リードしています。


学歴

• 2003年にバルセロナ大学で医学博士号を取得。
• 2008年にバルデヘブロンがん研究所（VHIO）で医学腫瘍学フェローシップを取得。
• 2008年、ノースカロライナ大学チャペルヒル校（アメリカ）で、チャールズ・M・ペロー教授の研究室でポストドクトラル研究員として活動。

キャリア

• アウグスト・ピ・イ・スニェール生物医学研究所（IDIBAPS）で、固形腫瘍のトランスレーショナルゲノミクスと標的治療のグループの責任者。
• SOLTIの取締役会会長。
• 2018年にBreast International Group (BIG)の執行委員会メンバー。
• Reveal Genomics, SLというスピンオフの共同創設者。
• 3件の発明特許を保持しており、安定した科学的キャリアを証明しています。
• 2012年よりVHIOのトランスレーショナルゲノミクスグループ長。
• Hospital Clínic およびIDIBAPS（2014年）。

出版物

170以上の出版物（H指数51）、合計13,479引用、95件の国際会議での発表を行っています。

教育

• バルセロナ大学のテニュアトラック教授
• ディレクター、乳房病理学 – セノロジーマスターの学位、UB。

Education and Training:

Medical Degree: Graduated from Universidad Miguel Hernández de Elche (1993–1999).​

Dermatology Residency: Completed at Hospital General Universitario de Alicante (2000–2004).​

Dermatopathology Fellowships: Undertook specialized training at St John's Institute of Dermatology in London and in Winston-Salem, North Carolina, USA (2003).​

International Certification: Achieved the International Board Certification in Dermatopathology (ICDP-UEMS) in 2007

Advanced Training in Hidradenitis Suppurativa: Completed at Hospital de Roskilde, Copenhagen, Denmark (2015).​

Professional Experience:

Hospital General Universitario de Elche: Served as a dermatologist from 2004 to 2010.​

Hospital General Universitario de Alicante: Practicing dermatologist since 2010.​

Hospital Quirónsalud Torrevieja: Specialist in Dermatology since 2006.​

Quirónsalud Alicante: Specialist in Dermatology.​

Research and Publications:

Authored over 50 national and international scientific publications.​

Regular presenter at various dermatology and dermatopathology conferences.​

Professional Affiliations:

Member of the Spanish Academy of Dermatology and Venereology (AEDV).​

Member of the Spanish Group of Dermatopathology.​

Member of the European Hidradenitis Suppurativa Foundation.​

Member of the International Society of Dermoscopy.​

Dr. Pascual Ramírez's comprehensive training and active involvement in research and professional societies underscore his commitment to advancing dermatological care and education.

Specialties

-General and Digestive Surgery

-Laparoscopic Surgery (Minimally Invasive Techniques)

-Surgical Oncology

-HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

-Colorectal, Gastric, and Peritoneal Cancer Surgery

Current Position

Senior Surgeon, Department of General and Digestive Surgery

Hospital Quirónsalud Torrevieja, Spain

Clinical Expertise

Minimally invasive cancer surgery with laparoscopic and robotic techniques

Cytoreductive surgery with HIPEC for peritoneal carcinomatosis

Colorectal cancer, gastric cancer, and complex abdominal surgeries

Multidisciplinary treatment planning for gastrointestinal malignancies

Academic & Research Contributions

Author of numerous peer-reviewed publications and book chapters in surgical oncology

Frequent speaker at international congresses on advanced surgical oncology and HIPEC

Actively involved in clinical research and surgical training programs

Professional Recognition

Widely regarded as a reference in Spain and internationally for HIPEC and advanced laparoscopic cancer surgery

Mentor to upcoming surgeons in the field of minimally invasive oncologic surgery

Research and Publications:

Extensive Scholarly Work: Authored and co-authored over 48 publications focusing on surgical oncology, hepatobiliary surgery, and innovative cancer treatments. His research has garnered over 1,100 citations, reflecting significant contributions to the medical community. ​

Professional Affiliations:

Academic Roles: Serves as an Associate Professor in the Department of Health Sciences at Saint Anthony Catholic University in Murcia, Spain, since January 2014

Education and Training

Doctor of Medicine, Cum Laude, University of Navarra (1991)

Medical Degree, University of Navarra (1979–1985), Graduated with Honors

Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)

Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA

Professional Experience

Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia

Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department

Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)

Clinical Innovations & Special Programs

Personalized Cancer Therapy using RNA microarrays and pharmacogenomics

Autologous Bone Marrow Transplants and High-Dose Chemotherapy

High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors

Personalized Cellular Anti-Tumor Vaccines

Hyperthermic Isolated Limb Perfusion with TNF and melphalan

Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers

Research & Academic Contributions

Author of 120+ scientific papers and conference presentations

Active contributor to the development of novel cancer immunotherapies and drug personalization strategies

Memberships

AACR – American Association for Cancer Research

ASCO – American Society of Clinical Oncology

ASH – American Society of Hematology

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

Dr. César Lévano Linares is a specialist in general and digestive surgery. He works at Rey Juan Carlos University Hospital and Fundación Jiménez Díaz University Hospital. He is recognized for his work in laparoscopic colorectal surgery.

He holds a PhD in Medicine and Surgery from the Autonomous University of Madrid. He completed a master’s in colorectal and pelvic floor surgery at the University of Zaragoza. He also holds a diploma in laparoscopic surgery from Louis Pasteur University in Strasbourg. He has European accreditation in laparoscopic surgery (EACCME).

His research covers bilateral retroperitoneal hibernoma and conversion from primary endoluminal endoscopic surgery to laparoscopic gastric bypass.

Dr. José Miguel Esteban López-Jamar is a gastroenterologist. He has led the Digestive Endoscopy and Digestive Diseases Units at Hospital Ruber Internacional since 2007. He has more than 20 years of experience. He is a Spanish pioneer in endoscopic ultrasound (EUS). His work covers diagnostic and interventional endoscopy. He uses innovative, minimally invasive techniques for complex gastrointestinal disease.

He was Head of Endoscopy (2008–2012) and Head of Endoscopic Innovation (2012–2014) at Hospital Clínico San Carlos. He completed international training at AMC Amsterdam, Institut Paoli-Calmettes in Marseille, and Zhongshan Hospital in Shanghai. He holds an MD and a PhD from the Complutense University of Madrid. He is a specialist in gastroenterology. He takes part in multicenter European studies and clinical trials. He is a member of SEPD, SEED, and ESGE.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.